Giuseppe Floris

13.2k total citations · 1 hit paper
118 papers, 2.6k citations indexed

About

Giuseppe Floris is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giuseppe Floris has authored 118 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 54 papers in Cancer Research and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giuseppe Floris's work include Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (21 papers) and Gastrointestinal Tumor Research and Treatment (20 papers). Giuseppe Floris is often cited by papers focused on Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (21 papers) and Gastrointestinal Tumor Research and Treatment (20 papers). Giuseppe Floris collaborates with scholars based in Belgium, Italy and United States. Giuseppe Floris's co-authors include Hans Wildiers, Patrick Neven, Patrick Schöffski, Ann Smeets, Maria Dêbiec‐Rychter, Raf Sciot, Agnieszka Woźniak, Sigrid Hatse, Kevin Punie and Ines Nevelsteen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Giuseppe Floris

104 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

2021 442 citations Ayse Bassez, Hanne Vos et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppe Floris Belgium	28	1.1k	793	670	642	468	118	2.6k
Shunchang Jiao China	30	1.9k 1.7×	1.1k 1.4×	977 1.5×	655 1.0×	618 1.3×	144	3.4k
Simon Pernot France	25	2.2k 2.0×	759 1.0×	1.1k 1.6×	609 0.9×	938 2.0×	99	3.5k
Christina L. Roland United States	30	1.7k 1.5×	945 1.2×	1.4k 2.1×	585 0.9×	484 1.0×	126	3.6k
Hei‐Cheul Jeung South Korea	31	1.2k 1.1×	868 1.1×	1.2k 1.8×	443 0.7×	178 0.4×	138	2.8k
Kohei Murata Japan	32	1.1k 1.0×	1.6k 2.0×	690 1.0×	517 0.8×	312 0.7×	187	3.3k
Tobias Janowitz United States	22	2.0k 1.8×	1.0k 1.3×	816 1.2×	574 0.9×	1.1k 2.5×	53	3.6k
Yasuto Uchikado Japan	31	1.4k 1.3×	1.1k 1.4×	1.0k 1.5×	519 0.8×	434 0.9×	127	3.0k
Masahiro Gotoh Japan	30	727 0.6×	1.7k 2.2×	747 1.1×	452 0.7×	156 0.3×	80	3.2k
Karl‐Heinz Thierauch Germany	19	908 0.8×	1.0k 1.3×	502 0.7×	409 0.6×	146 0.3×	33	2.5k

Countries citing papers authored by Giuseppe Floris

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Floris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Floris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Floris more than expected).

Fields of papers citing papers by Giuseppe Floris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Floris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Floris. The network helps show where Giuseppe Floris may publish in the future.

Co-authorship network of co-authors of Giuseppe Floris

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Floris. A scholar is included among the top collaborators of Giuseppe Floris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Floris. Giuseppe Floris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baelen, Karen Van, Hans Wildiers, Giuseppe Floris, et al.. (2024). Abstract PO3-05-05: The effect of histological breast cancer subtype on progression free survival in patients with CDK4/6 inhibitors. Cancer Research. 84(9_Supplement). PO3–5.

Bockstal, Mieke Van, Yves Guiot, Dominique Dubois, et al.. (2024). Evaluation of trophoblast cell surface antigen-2 (TROP2) protein expression in chemotherapy-resistant and metastatic breast carcinomas. Pathology - Research and Practice. 264. 155724–155724. 1 indexed citations

Laenen, Annouschka, Machteld Keupers, Ines Nevelsteen, et al.. (2024). Expression patterns of H3K27me3 for differentiation of breast fibroadenomas and phyllodes tumors. Apmis. 133(1). e13485–e13485. 2 indexed citations

Bassez, Ayse, Hanne Vos, Laurien Van Dyck, et al.. (2021). A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nature Medicine. 27(5). 820–832. 442 indexed citations breakdown →

Bempt, Isabelle Vanden, Hans Wildiers, Ann Smeets, et al.. (2021). Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2− early breast cancer. Modern Pathology. 34(7). 1297–1309. 7 indexed citations

Lefrère, Hanne, Giuseppe Floris, Marjanka K. Schmidt, et al.. (2021). Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome. European Journal of Cancer. 155. 13–24. 8 indexed citations

Deman, Frederik, Kevin Punie, Annouschka Laenen, et al.. (2020). Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes. Breast Cancer Research and Treatment. 184(3). 985–998. 9 indexed citations

Bockstal, Mieke Van, Marcella Baldewijns, Cécile Colpaert, et al.. (2018). Dichotomous histopathological assessment of ductal carcinomain situof the breast results in substantial interobserver concordance. Histopathology. 73(6). 923–932. 16 indexed citations

Gerosa, Clara, Daniela Fanni, Giuseppe Floris, et al.. (2017). Depleted Uranium and Human Health. Current Medicinal Chemistry. 25(1). 49–64. 76 indexed citations

10.

Looy, Thomas Van, Agnieszka Woźniak, Giuseppe Floris, et al.. (2014). Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and Efficacy. Clinical Cancer Research. 20(23). 6071–6082. 42 indexed citations

11.

Floris, Giuseppe, Sileny Han, & Frédéric Amant. (2014). Pregnancy-associated breast cancer. SHILAP Revista de lepidopterología. 2 indexed citations

12.

Gerosa, Clara, Vassilios Fanos, Daniela Fanni, et al.. (2013). Liver biopsy interpretation in the differential diagnosis of autoimmune liver disease in children. SHILAP Revista de lepidopterología. 2 indexed citations

13.

Smeets, Ann, Barbara Brouwers, Sigrid Hatse, et al.. (2013). Circulating CCL5 Levels in Patients with Breast Cancer: Is There a Correlation with Lymph Node Metastasis?. Lirias (KU Leuven). 2013. 1–5. 8 indexed citations

14.

Floris, Giuseppe, Agnieszka Woźniak, Raf Sciot, et al.. (2012). A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal. Clinical Cancer Research. 19(3). 620–630. 59 indexed citations

15.

Brouckaert, Olivier, Annouschka Laenen, Joke Vanderhaegen, et al.. (2012). Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. Annals of Oncology. 23(10). 2578–2584. 45 indexed citations

16.

Floris, Giuseppe, Raf Sciot, Agnieszka Woźniak, et al.. (2011). The Novel HSP90 Inhibitor, IPI-493, Is Highly Effective in Human Gastrostrointestinal Stromal Tumor Xenografts Carrying Heterogeneous KIT Mutations. Clinical Cancer Research. 17(17). 5604–5614. 41 indexed citations

17.

Floris, Giuseppe, Maria Dêbiec‐Rychter, Agnieszka Woźniak, et al.. (2011). The Heat Shock Protein 90 Inhibitor IPI-504 Induces KIT Degradation, Tumor Shrinkage, and Cell Proliferation Arrest in Xenograft Models of Gastrointestinal Stromal Tumors. Molecular Cancer Therapeutics. 10(10). 1897–1908. 37 indexed citations

18.

Dewaele, Barbara, Giuseppe Floris, Christopher Fletcher, et al.. (2010). Coactivated Platelet-Derived Growth Factor Receptor α and Epidermal Growth Factor Receptor Are Potential Therapeutic Targets in Intimal Sarcoma. Cancer Research. 70(18). 7304–7314. 68 indexed citations

19.

Floris, Giuseppe, Maria Dêbiec‐Rychter, Raf Sciot, et al.. (2009). High Efficacy of Panobinostat Towards Human Gastrointestinal Stromal Tumors in a Xenograft Mouse Model. Clinical Cancer Research. 15(12). 4066–4076. 49 indexed citations

20.

Floris, Giuseppe, Maria Dêbiec‐Rychter, Agnieszka Woźniak, et al.. (2007). Malignant Ectomesenchymoma: Genetic Profile Reflects Rhabdomyosarcomatous Differentiation. Diagnostic Molecular Pathology. 16(4). 243–248. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact